Charts

21 Nov, 2022
12:00
Seeking Alpha
17 Nov, 2022
23:14
Seeking Alpha

News

15 Nov, 2022
In its Q3 earnings release,Exicure Inc's(NASDAQ:XCUR) managementwarned of substantial ...
14 Nov, 2022
Exicure reported financial results for the quarter ended September 30, 2022 and provided an update on its business strategy and corporate progress.
02 Nov, 2022
Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results ...
07 Oct, 2022
Gainers NeuroMetrix (NASDAQ:NURO) stock moved upwards by 29.0% to $3.65 during Friday's after-market session. This security traded ...
28 Sep, 2022
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 106.3% to close at $9.15. Avenue Therapeutics recently received ...
27 Sep, 2022
U.S. stocks traded lower, with the Dow Jones dropping around 180 points on Tuesday. Here are some big stocks recording losses in ...
Exicure Inc(NASDAQ: XCUR) announcedrestructuring plansand aligned resources to continue exploring strategic ...
Pre-open movers U.S. stock futures traded higher in early pre-market trade on Tuesday after recording losses on Monday. The Dow Jones ...
With US stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as ...
26 Sep, 2022
Exicure announced plans to restructure the Company and align resources to continue exploring strategic alternatives that maximize stockholder value.
CHICAGO, September 26, 2022--Exicure announced plans to restructure the Company and align resources to continue exploring strategic alternatives that maximize stockholder value.
01 Sep, 2022
Exicure CEO Matthias Schroff will provide a live presentation at the 2022 Chardan Genetic Medicines Conference.
30 Aug, 2022
Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares rose 28.1% to $3.33 in pre-market trading after gaining over 5% on ...
24 Aug, 2022
Gainers Minerva Neurosciences (NASDAQ:NERV) shares increased by 16.6% to $5.26 during Wednesday's pre-market ...
17 Aug, 2022
15 Aug, 2022
Exicure today reported financial results for the quarter ended June 30, 2022 and provided an update on its business strategy and corporate progress.
Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 31.2% to $0.6931 in pre-market trading as the company presented ...
05 Aug, 2022
Gainers Marker Therapeutics (NASDAQ:MRKR) stock moved upwards by 121.9% to $0.73 during Friday's pre-market session. ...
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced ...
04 Aug, 2022
Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on ...
Gainers InVivo Therapeutics Hldg (NASDAQ:NVIV) stock increased by 109.5% to $9.26 during Thursday's pre-market ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! It's time for another dive into the biggest pre-market stock movers as we see what's affecting shares on Thursday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” Cash Holders Could Get Hit Hard THIS FRIDAY
Gainers Missfresh Limited (NASDAQ: MF) shares rose 112.9% to $0.2450 in pre-market trading after dropping 7% on ...
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average ...
03 Aug, 2022
Gainers Exicure (NASDAQ:XCUR) shares increased by 97.0% to $3.92 during Wednesday's after-market session. This security traded at a ...
20 Jul, 2022
Exicure, Inc. (Nasdaq: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that on July 19, 2022, it received a letter from the Office of General Counsel of The Nasdaq Stock Market LLC informing it that Nasdaq has confirmed that the Company has regained compliance with the $1.00 per share minimum bid price requirement pursuant to Nasdaq Listing Rule 5450(a)(1) and that the Company is in compliance with all applicable listing standards. Accordingly, the scheduled hearing before the Nasdaq Hearings Panel has been cancelled and the Company’s Common Stock will continue to be listed and traded on The Nasdaq Capital Market.
11 Jul, 2022
Gainers Novo Integrated Sciences (NASDAQ:NVOS) shares increased by 21.7% to $2.3 during Monday's after-market session. The market ...
07 Jul, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 39.6% to $0.2471 in pre-market trading after declining over 8% on ...
01 Jul, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It's time for another look at the biggest pre-market stock movers as we dive into the latest news for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace $200 Oil Sooner Than You Think – Buy This Now The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 in savings or $5 million. Do this now.
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. ...
30 Jun, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation ...
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus US Government Calls For ...
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company ...
29 Jun, 2022
Gainers Allena Pharma (NASDAQ:ALNA) stock moved upwards by 166.4% to $0.32 during Wednesday's regular session. Trading volume for ...
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its ...
Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that, following the implementation of a one-for-thirty reverse stock split at 5:00 p.m. EDT today, the Company’s common stock will begin trading on a split-adjusted basis on Nasdaq effective with the open of business tomorrow, Thursday, June 30, 2022. The Company’s common stock will continue to trade under the ticker symbol “XCUR”. The new CUSIP number for the post-reverse split common shares is 30205M 200. The Company is implementing the reverse stock split in an effort to regain compliance with Nasdaq’s minimum bid price requirement of $1.00 per share.
13 Jun, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, traders! We're starting off the week with a dive into the biggest pre-market stock movers for Monday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
09 Jun, 2022
09:44
FinancialContent
Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of ...
08 Jun, 2022
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million ...
Gainers Cyren Ltd. (NASDAQ: CYRN) rose 31.1% to $2.32 in pre-market trading after the company entered into an agreement with ...
27 May, 2022
Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that the Company’s Annual Meeting of Stockholders (the “Annual Meeting”) held in virtual format on Friday, May 27, 2022 at 1:00 p.m. Central Time, was convened and adjourned until June 10, 2022 at 1:00 p.m. Central Time without any business being conducted. The Company adjourned the Annual Meeting for the purpose of allowing additional time for stockholders to vote on Proposal 3, described below and as set forth in the Company’s proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on April 12, 2022 (the “Proxy Statement”). The business scheduled for the re-convened meeting remains the same as set forth in the Proxy Statement.
23 May, 2022
07:57
FinancialContent
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 ...
20 May, 2022
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 200 points on Friday. The Dow traded down 0.64% ...
Gainers Leju Holdings Limited (NYSE: LEJU) surged 27.8% to $4.0413. TherapeuticsMD, Inc. (NASDAQ: TXMD) shares jumped 25.6% to ...
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Recommends COVID-19 ...
17 May, 2022
CHICAGO, May 17, 2022--Exicure today announced that CEO Matthias Schroff will provide a virtual presentation at the 2022 H.C. Wainwright Global Life Sciences Conference.
16 May, 2022
CHICAGO, May 16, 2022--Exicure today reported financial results for the quarter ended March 31, 2022 and provided an update on its business strategy and corporate progress.
10 May, 2022
CHICAGO, May 10, 2022--Exicure, Inc.® (NASDAQ:XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that it has agreed to sell an aggregate of 26,021,111 shares of its common stock at a purchase price of $0.1937 per share to certain accredited investors in a private placement in public equity ("PIPE") financing. The purch
09 May, 2022
CHICAGO, May 09, 2022--Exicure, Inc. today announced a poster presentation at TIDES USA 2022, May 9-12, 2022.
25 Mar, 2022
20:26
Seeking Alpha
CHICAGO, March 25, 2022--Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today reported full year financial results for the quarter and year ended December 31, 2021 and provided an update on its business strategy and corporate progress.
04 Feb, 2022
CHICAGO, February 04, 2022--Exicure, Inc. Announces Leadership Transition and Changes to the Board of Directors
05 Jan, 2022
New York, NY, based Investment company Neville Rodie & Shaw Inc (Current Portfolio) buys Cleveland-Cliffs Inc, Palo Alto Networks Inc, Novo Nordisk A/S, United Rentals Inc, CAE Inc, sells , Verizon Communications Inc, Trane Technologies PLC, Lululemon Athletica Inc, Organon during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Neville Rodie & Shaw Inc.
01 Jan, 2022
Upcoming Deadline Reminder: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm
31 Dec, 2021
23:02
Yahoo! Finance
Exicure Class Action Reminder
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exicure, Inc. ("Exicure" or "the Company") (NASDAQ: XCUR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
LOS ANGELES, CA / ACCESSWIRE / December 31, 2021 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Exicure, Inc. ("Exicure" or "the Company") (NASDAQ:XCUR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.
30 Dec, 2021
22:57
Yahoo! Finance
Exicure Shareholder Notice
Shareholder Action Notice: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to Contact the Firm
19 Nov, 2021
10 Sep, 2021
19:55
Seeking Alpha
12 Aug, 2021
23 Mar, 2021
31 Dec, 2020
18:30
Seeking Alpha
12 Nov, 2020
01 Oct, 2020
12 Aug, 2020

Related Articles